While proteins on the surfaces of cells are the
targets for most drugs, refined methods are needed to analyze how
these membrane proteins are organized. Researchers at Karolinska
Institutet have developed a new DNA-based analytical method that
could contribute to the development of future drugs for breast and
other cancers. The study is published in Nature
Nanotechnology.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
